Meeting Coverage
MDS
Movement Disorder Societies
Randomized controlled trial clashes with epidemiologic data
Latest MDS Meeting Coverage
But phase I study of one agent pulled from presentation
Drugmaker Acorda to seek FDA approval shortly
But meta-analysis includes only two Taiwanese claims studies
Some non-motor symptoms may be ideal 'PRO' candidates
But patients reported improvements in impulsivity, inattention
Researchers enrolled 336 early Parkinson's patients within a year
Longitudinal study finds 16% have baseline anxiety, 37% develop it over time
Only 11% of patients had used it in Medicare study
Patch form of dopamine agonist also lowered nighttime activity
Inhaler eased breakthrough motor symptoms between standard levodopa doses in an early study
Most patients respond to injected drug within 20 minutes
SYDNEY -- Parkinson's disease patients who have impaired cognition appeared to benefit from the Alzheimer's disease medicine donepezil (Aricept) with no detriment to their motor skills, researchers reported here.